These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19223664)

  • 1. Activation and desensitization of nicotinic alpha7-type acetylcholine receptors by benzylidene anabaseines and nicotine.
    Papke RL; Kem WR; Soti F; López-Hernández GY; Horenstein NA
    J Pharmacol Exp Ther; 2009 May; 329(2):791-807. PubMed ID: 19223664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-to-point ligand-receptor interactions across the subunit interface modulate the induction and stabilization of conformational states of alpha7 nAChR by benzylidene anabaseines.
    Isaacson MD; Horenstein NA; Stokes C; Kem WR; Papke RL
    Biochem Pharmacol; 2013 Mar; 85(6):817-28. PubMed ID: 23352650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive modulation of alpha7 nAChR responses in rat hippocampal interneurons to full agonists and the alpha7-selective partial agonists, 4OH-GTS-21 and S 24795.
    López-Hernández GY; Thinschmidt JS; Morain P; Trocme-Thibierge C; Kem WR; Soti F; Papke RL
    Neuropharmacology; 2009 Mar; 56(4):821-30. PubMed ID: 19705574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.
    Grønlien JH; Håkerud M; Ween H; Thorin-Hagene K; Briggs CA; Gopalakrishnan M; Malysz J
    Mol Pharmacol; 2007 Sep; 72(3):715-24. PubMed ID: 17565004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the molecular mechanism of the α7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states.
    Williams DK; Wang J; Papke RL
    Mol Pharmacol; 2011 Dec; 80(6):1013-32. PubMed ID: 21885620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced inhibition of a mutant neuronal nicotinic acetylcholine receptor by agonists: protection of function by (E)-N-methyl-4-(3-pyridinyl)-3-butene-1-amine (TC-2403).
    Papke RL
    J Pharmacol Exp Ther; 2002 May; 301(2):765-73. PubMed ID: 11961083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of benzylidene-anabaseine analogues with agonist and allosteric sites on muscle nicotinic acetylcholine receptors.
    Arias HR; Xing H; Macdougall K; Blanton MP; Soti F; Kem WR
    Br J Pharmacol; 2009 May; 157(2):320-30. PubMed ID: 19338581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Activation and Desensitization States Promoted by Noncanonical
    Stokes C; Camacho-Hernandez GA; Thakur GA; Wu X; Taylor P; Papke RL
    J Pharmacol Exp Ther; 2022 Nov; 383(2):157-171. PubMed ID: 36279397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive binding at a nicotinic receptor transmembrane site of two α7-selective positive allosteric modulators with differing effects on agonist-evoked desensitization.
    Collins T; Young GT; Millar NS
    Neuropharmacology; 2011 Dec; 61(8):1306-13. PubMed ID: 21820451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha7 receptor-selective agonists and modes of alpha7 receptor activation.
    Papke RL; Meyer E; Nutter T; Uteshev VV
    Eur J Pharmacol; 2000 Mar; 393(1-3):179-95. PubMed ID: 10771012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of agonist selectivity by mutations of conserved amino acids in the binding site of nicotinic acetylcholine receptors.
    Horenstein NA; McCormack TJ; Stokes C; Ren K; Papke RL
    J Biol Chem; 2007 Feb; 282(8):5899-909. PubMed ID: 17189260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.
    Hurst RS; Hajós M; Raggenbass M; Wall TM; Higdon NR; Lawson JA; Rutherford-Root KL; Berkenpas MB; Hoffmann WE; Piotrowski DW; Groppi VE; Allaman G; Ogier R; Bertrand S; Bertrand D; Arneric SP
    J Neurosci; 2005 Apr; 25(17):4396-405. PubMed ID: 15858066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization and high-throughput screening of positive allosteric modulators of α7 nicotinic acetylcholine receptors in IMR-32 neuroblastoma cells.
    Gopalakrishnan SM; Philip BM; Gronlien JH; Malysz J; Anderson DJ; Gopalakrishnan M; Warrior U; Burns DJ
    Assay Drug Dev Technol; 2011 Dec; 9(6):635-45. PubMed ID: 21309712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silent agonists for α7 nicotinic acetylcholine receptors.
    Papke RL; Quadri M; Gulsevin A
    Pharmacol Res; 2023 Apr; 190():106736. PubMed ID: 36940890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counteracting desensitization of human α7-nicotinic acetylcholine receptors with bispyridinium compounds as an approach against organophosphorus poisoning.
    Scheffel C; Niessen KV; Rappenglück S; Wanner KT; Thiermann H; Worek F; Seeger T
    Toxicol Lett; 2018 Sep; 293():149-156. PubMed ID: 29248576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis.
    Papke RL; Porter Papke JK
    Br J Pharmacol; 2002 Sep; 137(1):49-61. PubMed ID: 12183330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structural basis for GTS-21 selectivity between human and rat nicotinic alpha7 receptors.
    Stokes C; Papke JK; Horenstein NA; Kem WR; McCormack TJ; Papke RL
    Mol Pharmacol; 2004 Jul; 66(1):14-24. PubMed ID: 15213292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple modes of α7 nAChR noncompetitive antagonism of control agonist-evoked and allosterically enhanced currents.
    Peng C; Kimbrell MR; Tian C; Pack TF; Crooks PA; Fifer EK; Papke RL
    Mol Pharmacol; 2013 Sep; 84(3):459-75. PubMed ID: 23839567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators using the parallel oocyte electrophysiology test station.
    Malysz J; Grønlien JH; Timmermann DB; Håkerud M; Thorin-Hagene K; Ween H; Trumbull JD; Xiong Y; Briggs CA; Ahring PK; Dyhring T; Gopalakrishnan M
    Assay Drug Dev Technol; 2009 Aug; 7(4):374-90. PubMed ID: 19689206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
    Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
    J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.